Regulation of the hypoxia-dependent plasminogen activator inhibitor 1 expression by MAP kinases

Thomas Kietzmann1, Kurt Jungermann, Agnes Görlach

  • 1Institut für Biochemie und Molekulare Zellbiologie, Humboldtallee 23, D-37073 Göttingen, Germany. tkietzmn@gwdg.de

Insights

Mitogen-activated protein kinases (MAPKs) and protein kinase B (PKB) influence hypoxia-induced plasminogen activator inhibitor-1 (PAI-1) expression. These signaling pathways, particularly p38 and PKB, enhance PAI-1 levels during the hypoxic response.

Area of Science:

  • Cellular signaling pathways
  • Molecular biology
  • Hypoxia research

Background:

  • Mitogen-activated protein kinases (MAPKs) and protein kinase B (PKB) are key mediators of cellular growth and stress responses.
  • These signaling pathways have been implicated in the cellular response to hypoxia (low oxygen conditions).
  • Hypoxia-inducible factor 1 (HIF-1) is the primary regulator of plasminogen activator inhibitor-1 (PAI-1) expression under hypoxia, but the roles of MAPKs and PKB in this process are not fully understood.

Purpose of the Study:

  • To investigate the involvement of MAPKs and PKB in the regulation of PAI-1 expression during hypoxia.
  • To elucidate the specific roles of p38 and PKB signaling in HIF-1-mediated PAI-1 induction.

Main Methods:

  • Utilized HepG2 cells treated with specific inhibitors (SB203580 for p38, LY294002 for PI3K, PD98059 for MEK1).
  • Employed overexpression of PKB, p38 upstream kinases (MKK6, MKK3), JNK, and ERK.
  • Assessed PAI-1 mRNA levels and reporter gene activity (luciferase assays) using hypoxia-inducible and HIF-dependent constructs.
  • Measured HIF-1alpha protein levels.

Main Results:

  • Inhibition of p38 (SB203580) and PI3K (LY294002) abrogated hypoxia-induced PAI-1 expression, while MEK1 inhibition (PD98059) had no effect.
  • Overexpression of PKB, MKK6, MKK3, and JNK, but not ERK, led to increased PAI-1 mRNA levels.
  • Cells overexpressing MKK3, MKK6, or PKB showed enhanced PAI-1 promoter activity and increased HIF-1alpha protein levels.

Conclusions:

  • The p38 and PKB signaling pathways play a significant role in enhancing PAI-1 levels during the hypoxic response.
  • These pathways contribute to the regulation of HIF-1alpha protein levels and subsequent PAI-1 induction under low oxygen conditions.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...